Head-to-head comparison
Curex vs REMEVi
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Identical $199 pricing on both molecules, plus oral routes and nationwide reach — simple math for switchers.
$199/mo sema · $199/mo tirz
Marked down on: No brand-name access
FDAWarning letter issued to Curex in September 2025. See the FDA warning-letter database.
Desk Score
A flat $219 a month for semaglutide and $319 for tirzepatide at every dose, lower on 12- and 24-week plans, with four named pharmacies and the whole program in English or Spanish.
$219/mo sema · $319/mo tirz · Verified August 2026
Marked down on: The flat rate is a higher entry price than teaser-led competitors
Curex takes this head-to-head with the higher Desk Score, 89/100 (B+) against 86/100 (B) for REMEVi. REMEVi still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Curex
89/100
B+
REMEVi
86/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Curex | REMEVi |
|---|---|---|
| Semaglutide | $199/mo$199/mo | $219/mo$219/mo month-to-month; $189/mo on a 12-week plan; $179/mo on a 24-week plan; same price at every dose; oral tablet $349/mo month-to-month or $309/mo on a 12-week plan |
| Tirzepatide | $199/mo$199/mo | $319/mo$319/mo month-to-month; $249/mo on a 12-week plan; $229/mo on a 24-week plan; same price at every dose; compounded injectable |
| Coverage | All 50 states | All 50 states and DC |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | People who may switch between semaglutide and tirzepatide and want one predictable price for either. | Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language. |
| Desk Score | 89/100B+ | 86/100B |
The verdict
Desk pick — CurexCurex takes this head-to-head with the higher Desk Score, 89/100 (B+) against 86/100 (B) for REMEVi. REMEVi still holds its ground where its strengths line up with yours.
Choose Curex if…
People who may switch between semaglutide and tirzepatide and want one predictable price for either.
$199/mo sema · $199/mo tirz · All 50 states
FDAWarning letter issued to Curex in September 2025. See the FDA warning-letter database.
Choose REMEVi if…
Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language.
$219/mo sema · $319/mo tirz · All 50 states and DC
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Curex · REMEVi.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Curex
- CoreAge Rx vs REMEVi
- Curex vs Shed
- BetterMe Rx vs REMEVi
- Curex vs Tyde Wellness
- Fitish vs REMEVi
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.